Drawing for GIVE SEIZURES THE SPRAYER

USPTO serial 97354935

GIVE SEIZURES THE SPRAYER

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LEE, CATHERINE ANNE
Law office
TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with GIVE SEIZURES THE SPRAYER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Perry J. Viscounty

Perry J. Viscounty LATHAM & WATKINS LLP650 TOWN CENTER DRIVE, SUITE 2000COSTA MESA, CA 92626United States

Goods and services

ClassDescriptionStatusFirst use
005Nasal spray preparations; pharmaceutical preparations for the treatment of nervous system disorders and epileptic seizures and anxiety; pharmaceutical preparations, namely, pain relief medication; pharmaceutical preparations for the treatment of pain and conditions associated with pain and epileptic seizures, and anxiety; pharmaceutical preparations for the treatment of nervous system disorders, epileptic seizures and anxiety, pain, and conditions associated with pain sold in pre-filled medical apparatus and drug delivery devicesACTIVEApr 14, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 15, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 15, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 31, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 31, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Nov 2, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 1, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2023CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 1, 2023EX1GSOU EXTENSION 1 GRANTED—
Nov 1, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 25, 2023IUAFUSE AMENDMENT FILED—
Oct 25, 2023EXT1SOU EXTENSION 1 FILED—
Oct 25, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 25, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 25, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 28, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 28, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 8, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 26, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2023DOCKASSIGNED TO EXAMINER—
Apr 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 12, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance